Close Menu
    What's Hot

    ReAssure Staff Pension Scheme Completes Bulk Purchase Annuity Transaction With Standard Life

    July 27, 2026

    Miller Retirement Benefits Scheme Completes Bulk Purchase Annuity Buy-In With M&G

    July 27, 2026

    Credit Commercial de France Pension Scheme Completes Bulk Purchase Annuity Buy-In With Royal London

    July 23, 2026
    X (Twitter) LinkedIn
    Longevity & Mortality Investor
    • Home
    • Coverage
      1. Life Insurance Capital Solutions
      2. Life Insurance
      3. Longevity and Mortality Risk Transfer
      4. Mortality
      5. Secondary Life Markets
      6. View All

      Big Year of Growth for Life/Annuity Sidecar-Like Activity in 2025

      July 2, 2026

      Sixth Street To Become Majority Shareholder of Monument Re

      June 30, 2026

      Pacific Life Re Appoints Florence Durousseau as Head of Capital Solutions, Europe

      June 15, 2026

      Third Block Reinsurance Deal With Tokio Marine & Nichido Life for Pacific Life Re

      June 10, 2026

      Shaping the Future of Health Insurance Through Innovation and Analytics

      June 10, 2026

      Q&A: Dr Christoph Schmitt, Director, Insurance, Fitch Ratings

      May 28, 2026

      Chronic Disease Onset and Cumulative Exposure: Clinical, Prognostic and Underwriting Implications

      May 13, 2026

      US Annuity Sales Notch Tenth Consecutive $100bn+ Quarter

      May 11, 2026

      ReAssure Staff Pension Scheme Completes Bulk Purchase Annuity Transaction With Standard Life

      July 27, 2026

      Miller Retirement Benefits Scheme Completes Bulk Purchase Annuity Buy-In With M&G

      July 27, 2026

      Credit Commercial de France Pension Scheme Completes Bulk Purchase Annuity Buy-In With Royal London

      July 23, 2026

      Smiths Industries Pension Scheme Completes Bulk Purchase Annuity Buy-In With M&G

      July 23, 2026

      Record Low Mortality Rates So Far in England and Wales in 2026

      July 9, 2026

      Organ Transplant Improvements Test Life Expectancy Assessment Models

      July 8, 2026

      The Pursuit of Everlasting Life Unlikely to Shift Actuarial Models

      June 10, 2026

      Pricing in the Unknown: Why Mortality Models Aren’t Ready for MCED Tests Just Yet

      April 9, 2026
      Litigation

      Litigation Update: Estate of Martha Barotz v. Wilmington Savings Fund Society, FSB, et al.

      July 22, 2026

      South Dakota Supreme Court Upholds Life Settlement Investor’s Right to Retain $10 Million Death Benefit

      July 22, 2026

      Optimism for Stronger Second Half in the Life Settlement Tertiary Market

      July 8, 2026

      US Life Insurers Embrace Securitised Credit as Demand for Yield and Diversification Grows but Hurdles Remain for Longevity-Linked Assets

      July 8, 2026

      ReAssure Staff Pension Scheme Completes Bulk Purchase Annuity Transaction With Standard Life

      July 27, 2026

      Miller Retirement Benefits Scheme Completes Bulk Purchase Annuity Buy-In With M&G

      July 27, 2026

      Credit Commercial de France Pension Scheme Completes Bulk Purchase Annuity Buy-In With Royal London

      July 23, 2026

      Smiths Industries Pension Scheme Completes Bulk Purchase Annuity Buy-In With M&G

      July 23, 2026
    • Events
    • Latest Issues

      Editor’s Letter – Volume 2, Issue 7, July 2026

      July 8, 2026

      Editor’s Letter – Volume 2, Issue 6, June 2026

      June 10, 2026

      Editor’s Letter – Volume 2, Issue 5, May 2026

      May 13, 2026

      Editor’s Letter – Volume 2, Issue 4, April 2026

      April 9, 2026

      Editor’s Letter – Volume 2, Issue 3, March 2026

      March 11, 2026
    • Contact Us
    Newsletter
    Longevity & Mortality Investor

    Q&A: Jay Jackson, CEO, Abacus Life

    Secondary Life Markets July 11, 2024By Greg Winterton
    Life Risk News Q&A
    Share
    Twitter LinkedIn Email

    Life settlement provider Abacus Life listed on the Nasdaq a year ago, a rarity in the life settlement market. Greg Winterton spoke to Jay Jackson, Founder and CEO at Abacus Life, to get his thoughts on a range of topics in the life settlement market. 

    GW: Jay, we’re into the second half of 2024 now, and both LISA and The Deal have published their annual data insights into activity in the secondary market. What are your thoughts on the results at an industry level? 

    JJ: Overall, I thought the results were encouraging for our industry. The life settlement market had a strong year in 2023 in both number of policies purchased, and total capital deployed. The growth can be attributed to an increase in awareness driven by not only television and digital marketing but also financial professional outreach. 

    GW: It’s approximately a year since Abacus listed on the Nasdaq. What are some of the lessons you’ve learned after being a public company for a year?

    JJ: The challenges of being a public company are the demands related to reporting. Historically, we would prepare for audits and reviews annually – now that occurs every 90 days. The markets are not only learning about our industry more frequently but are also scrutinizing the results every quarter. This level of scrutiny requires a higher level of accountability, transparency and operations. In addition, becoming a public company created additional transparency and regulatory review of not just our company but the industry, which has had a positive impact on the overall optics of our industry. 

    GW: Back to transactions now. The direct-to-consumer market, in which Abacus participates, has been growing generally in the past few years. Is this trend one that is something of a paradigm shift in the life settlement market, in the sense that the secondary market will increasingly see deal flow from this segment? 

    JJ: Our industry has been built on education. The challenge is the education can take significant time before an impact is made. The direct-to-consumer market is not different. It requires significant resources in both operations and capital to be successful. The benefit of direct-to-consumer education can be materialized through all origination channels. As companies continue to invest in education then there will be a positive impact for the entire industry. 

    GW: What about policy type and features – are you seeing more seasoned policies, or younger people looking to sell their policy, for example? Anything interesting at the type and insured level? 

    JJ:  We have seen a significant increase in the volume of larger face value contracts. We believe a cause for this shift is awareness from financial professionals as they are now communicating the benefits to their client’s estate. The optic of the transaction is shifting from a one-off small transaction for seniors who are in financial need to an estate planning tool used by high-net-worth households.   

    GW: Finally, Jay, back to the aforementioned secondary market activity data. What would you say is the main puzzle that needs to be solved in order to really get the life settlement industry moving in terms of secondary market deal flow? 

    JJ: Education and operations related to the documents used in acquisition. We as an industry should spend more time educating the states on a more streamlined document process. This is one piece of the puzzle that would have a significant impact on increased deal flow.   

    Jay Jackson is CEO at Abacus Life 

    2024 - July Life Settlements Q&A Volume 3 Issue 7 - July 2024
    Share. Twitter LinkedIn Email

    Related Posts

    Litigation

    Litigation Update: Estate of Martha Barotz v. Wilmington Savings Fund Society, FSB, et al.

    July 22, 2026By Greg Winterton

    South Dakota Supreme Court Upholds Life Settlement Investor’s Right to Retain $10 Million Death Benefit

    July 22, 2026By ArentFox Schiff

    Optimism for Stronger Second Half in the Life Settlement Tertiary Market

    July 8, 2026By Greg Winterton

    US Life Insurers Embrace Securitised Credit as Demand for Yield and Diversification Grows but Hurdles Remain for Longevity-Linked Assets

    July 8, 2026By Greg Winterton
    Latest Issue

    Optimism for Stronger Second Half in the Life Settlement Tertiary Market

    July 8, 2026

    Organ Transplant Improvements Test Life Expectancy Assessment Models

    July 8, 2026

    US Life Insurers Embrace Securitised Credit as Demand for Yield and Diversification Grows but Hurdles Remain for Longevity-Linked Assets

    July 8, 2026

    Passage of UK Pension Schemes Act Seen Boosting Size of DB Superfund Market

    June 24, 2026
    Ad

    Where Longevity and Mortality Meet the Markets
    ISSN 2978-5219

    X (Twitter) LinkedIn
    Coverage
    • Life Insurance Capital Solutions
    • Life Insurance
    • Longevity and Mortality Risk Transfer
    • Mortality Risk
    • Secondary Life Markets
    More Info
    • Home
    • About Us
    • Contact Us
    • Guest Articles
    • Submit Story Idea
    Our Newsletter
    Get the latest industry news, commentary and events from the Longevity & Mortality Investor directly into your inbox. Why not sign up today?

    © 2026 Longevity & Mortality Investor. Website by Kavells.
    • Sitemap
    • Privacy Policy
    • Copyright Notice
    • Terms & Conditions

    Type above and press Enter to search. Press Esc to cancel.